Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan. Karasawa Y, Kamae I, Nozawa K, Zeniya S, et al. PLoS One 2021;16:e0253547.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Karasawa Y, Kamae I, Nozawa K, Zeniya S, et al. Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan. PLoS One 2021;16:e0253547.
PMID: 34228745